Arkolith/Insider Trading/NBIX/Form 4

Gorman Kevin Charles

DirectorNEUROCRINE BIOSCIENCES INC (NBIX) · full profile →Form 4 · filed May 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$37.8M
Net Open-Market Flow
-$37.8M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2026Option exercise(M)205K$43.24$8.9M756K
May 19, 2026Sell(S)245K$154.33$37.8M511K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2026Option exercise(M)205K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001201096-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML